Angela Weyand/medschool.umich.edu
Jul 22, 2026, 14:31
What Could Shape the Future of Hemophilia A Care? – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Thank you to everyone who connected with us at ISTH26!
Hear Dr. Angela Weyand discuss her key takeaways from this year’s meeting and what they could mean for the future of hemophilia A care.
Discover ISTH resources from Novo Nordisk.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 14:58Radoš Stefanović: How Red Blood Cells Adapt After Exercise
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders
-
Oct 21, 2026, 13:52Negar Asdaghi: Could Cilostazol Improve Hematoma Clearance After ICH
-
Oct 21, 2026, 10:33Karen Schreiber: Beyond Clinical Outcomes – The Voices of Women with APS
-
Oct 21, 2026, 10:11Tau Braun: Clots Through the Copper-Zinc Model
-
Oct 21, 2026, 09:55Cristina Figueroa Villalba: Celebrating Excellence in Transfusion Medicine
-
Oct 21, 2026, 09:43Ahmad Gharehbaghian: How Can Blood Supplies Be Sustained During a Crisis?
-
Oct 21, 2026, 09:30Adrián Dante De Angelis: Research That Opens New Possibilities for Recurrent iTTP
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People